1,166
Views
5
CrossRef citations to date
0
Altmetric
Review

Therapeutic potential of glycyrrhetinic acids: a patent review (2010-2017)

, , , , , , & show all
Pages 383-398 | Received 16 Feb 2018, Accepted 19 Mar 2018, Published online: 26 Mar 2018

References

  • Li JY, Cao HY, Liu P, et al. Glycyrrhizic acid in the treatment of liver diseases: literature review. BioMed Res Int. 2014;872139.
  • Fiore C, Calo LA, Ragazzi E, et al. Licorice from antiquity to the end of the 19th century: applications in medical therapy. J Nephrol. 2004;17:337–341.
  • Armanini D, Nacamulli D, Francini-Pesenti F, et al. Glycyrrhetinic acid, the active principle of licorice, can reduce the thickness of subcutaneous thigh fat through topical application. Steroids. 2005;70:538–542.
  • Bahmani M, Rafieian-Kopaei M, Jeloudari M, et al. A review of the health effects and uses of drugs of plant licorice (Glycyrrhiza glabra L.). Iran Asian Pac J Trop Dis. 2014;4:S847–S849.
  • Zargaran A, Zarshenas MM, Mehdizadeh A, et al. Management of tremor in medieval Persia. J Hist Neurosci. 2013;22:53–61.
  • Hort A. Theophrastus: enquiry into plants and minor works on odours and weather signs. London: Harvard University Press; 1961. p. 13. Chapter IX.
  • Fiore C, Eisenhut M, Ragazzi E, et al. A history of the therapeutic use of liquorice in Europe. J Ethnopharmacol. 2005;99:317–324.
  • Marcellus. Marcelli De medicamentis, Teubneri, Lipsiae, liber, XIV, 7; XVI, 103; XX, 108; XXVI, 63; XXIX, 11; XXX, 24. 1889.
  • Toletanum G. Abub. Rhazae lib. De pestilentia ad Mansorem finis. In: Librum divisionium. Cremona; 1544. p. 371–374.
  • Von Sontheimer J. Grosse Zusammenstellung ueber die Kraefte der bekannten einfachen Heil-und Nahrungsmittel von Abu Mohammed Abdallah Ben Ahmed aus Malaga bekannt unter dem Namen Ebn Baithar. Aus dem Arabischen uebersetzt. Stuttgart: Hallberger’sche Verlagshandlung; 1842.
  • Scribonius. Scribonii Largi Compositiones: Teubner, Leipzig LXXV, LXXXVI. 1983.
  • Plinius. C. Plini Secundi Naturalis historiae, Teubneri, Lipsiae, libri XXXVII, XI, 119; XXII, 11; XXV, 43.II, IV. 1875 and 1897
  • Celsus. A. Cornelii Celsi De medicina libri octo. Vol. 20. Lipsiae: Teubneri; 1859. p. 6.
  • Avicenna. Liber canonis De Medicinis cordialibus Cantica De Removendis nocumentis in regimine sanitatis De syrupo acetoso. Iuntas, Venetiis II (2), 437. 1562.
  • Armanini D, Fiore C, Bielenberg J, et al. Licorice (Glycyrrhiza glabra). In: Coates P, editor. Encyclopedia of dietary supplements. New York (NY): Marcel Dekker; 2005. p. 371–399.
  • Blumenthal M, Goldberg A, Brinckmann J, et al. Herbal medicine- expanded commission E monographs. Austin (TX): American Botanical Council; 2000. p. 233–239.
  • Bradley PR. editor British herbal compendium. Vol. 1. Bournemouth: British Herbal Association; 1992. p. 145–148.
  • Wichtl M, Bisset NG, editor Herbal drugs and phytopharmaceuticals. Stuttgart: Medpharm Scientific Publishers; 1994. p. 486–489.
  • Armanini D, Fiore C, Matterello MJ, et al. History of the endocrine effects of licorice. Exp Clin Endocrinol Diabetes. 2002;110:257–261.
  • Ma J, Peng W, Liang D. Apoptosis of human gastric cancer cell line MGC-803 induced by glycyrrhiza uralensis extract. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2000;20:928–930.
  • Wang ZY, Nixon DW. Licorice and cancer. Nutr Cancer. 2001;39:1–11.
  • Kobayashi M, Fujita K, Katakura T, et al. Inhibitory effect of glycyrrhizin on experimental pulmonary metastasis in mice inoculated with B16 melanoma. Anticancer Res. 2002;22:4053–4058.
  • Fuhrman B, Buch S, Vaya J, et al. Licorice extract and its major polyphenol glabridin protect low-density lipoprotein against lipid peroxidation: in vitro and ex vivo studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am J Clin Nutr. 1997;66:267–275.
  • Fuhrman B, Volkova N, Kaplan M, et al. Antiatherosclerotic effects of licorice extract supplementation on hypercholesterolemic patients: increased resistance of LDL to atherogenic modification, reduced plasma lipid level, and decreased systolic blood pressure. Nutrition. 2002;18:268–273.
  • Saeedi M, Morteza-Semnani K, Ghoreishi MR. The treatment of atopic dermatitis with licorice gel. J Dermatolog Treat. 2003;14:153–157.
  • Badam I. In vitro antiviral activity of indigenous glycyrrhizin, licorice and glycyrrhizic acid (Sigma) on Japanese encephalitis virus. J Commun Disord. 1997;29:91–92.
  • Cinatl J, Morgenstern B, Bauer G, et al. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet. 2003;61:2045–2046.
  • Lin JC. Mechanism of action of glycyrrhizic acid in inhibition of Epstein Barr virus replication in vitro. Antivir Res. 2003;9:41–47.
  • Utsunomiya T, Kobayashi M, Pollard RB, et al. Glycyrrhizin, an active component of licorice roots, reduces morbidity and mortality of mice infected with lethal doses of influenza virus. Antimicrob Agents Chemother. 1997;41:551–556.
  • Sekizawa T, Yanagi K, Itoyama Y. Glycyrrhizin increases survival of mice with herpes simplex encephalitis. Acta Virologica. 2001;45:51–54.
  • Sasaki H, Takei M, Kobayashi M, et al. Effect of glycyrrhizin, an active component of licorice roots, on HIV replication in cultures of peripheral blood mononuclear cells from HIV-seropositive patients. Pathobiology. 2002;70:229–236.
  • Feng JH, Chen W, Zhao Y, et al. Anti-tumor activity of oleanolic, ursolic and glycyrrhetinic acid. Open Nat Prod J. 2009;2:48–52.
  • Amagaya S, Sugishita E, Ogihara Y, et al. Separation and quantitative analysis of 18α- glycyrrhetinic acid and 18β-glycyrrhetinic acid in glycyrrhizae radix by gas/3-liquid chromatography. J Chromatogr. 1985;320:430–434.
  • Sabbioni C, Mandrioli R, Ferranti A, et al. Separation and analysis of glycyrrhizin, 18β-glycyrrhetic acid and 18α-glycyrrhetic acid in liquorice roots by means of capillary zone electrophoresis. J Chromatogr. 2005;1081:65–71.
  • Xu B, Wu GR, Zhang XY, et al. An overview of structurally modified glycyrrhetinic acid derivatives as antitumor agents. Molecules. 2017;22:924–948.
  • Huang RY, Chu YL, Huang QC, et al. 18β-Glycyrrhetinic acid suppresses cell proliferation through inhibiting thromboxane synthase in non-small cell lung cancer. PLoS ONE. 2014;9:e93690.
  • Satomi Y, Nishino H, Shibata S. Glycyrrhetinic acid and related compounds induce G1 arrest and apoptosis in human hepatocellular carcinoma HepG2. Anticancer Res. 2005;25:4043–4047.
  • Li S, Zhu JH, Cao LP, et al. Growth inhibitory in vitro effects of glycyrrhizic acid in U251 glioblastoma cell line. Neurol Sci. 2014;35:1115–1120.
  • Csuk R, Schwarz S, Kluge R, et al. Synthesis and biological activity of some antitumor active derivatives from glycyrrhetinic acid. Eur J Med Chem. 2010;45:5718–5723.
  • Schwarz S, Csuk R, Ströhl D, et al. Synthesis and antitumor activity of glycyrrhetinic acid derivatives. Bioorg Med Chem. 2010;18:7458–7474.
  • Csuk R, Schwarz S, Kluge R. Improvement of the cytotoxicity and tumor selectivity of glycyrrhetinic acid by derivatization with bifunctional amino acids. Arch Pharm. 2011;344:505–513.
  • Csuk R, Schwarz S, Siewert B, et al. Synthesis and cytotoxic activity of methyl glycyrrhetinate esterified with amino acids. Z Naturforsch B. 2012;67:731–746.
  • Schwarz S, Siewert B, Xavier NM, et al. A “natural” approach: synthesis and cytoxicity of monodesmosidic glycyrrhetinic acid glycosides. Eur J Med Chem. 2014;72:78–83.
  • Lai Y, Shen L, Zhang Z, et al. Synthesis and biological evaluation of furoxan-based nitric oxide-releasing derivatives of glycyrrhetinic acid as anti-hepatocellularcarcinoma agents. Bioorg Med Chem Lett. 2010;20:6416–6420.
  • Chen S, Zou L, Li L, et al. The protective effect of glycyrrhetinic acid on carbon tetrachloride-induced chronic liver fibrosis in mice via upregulation of Nrf2. PLoS ONE. 2013;8:e53662.
  • Wang CY, Kao TC, Lo WH, et al. Glycyrrhizic acid and 18β-glycyrrhetinic acid modulate lipopolysaccharide-induced inflammatory response by suppression of NF-κB through PI3K p110δ and p110γ inhibitions. J Agric Food Chem. 2011;59:7726–7733.
  • Wang LJ, Geng CA, Ma YB, et al. Synthesis, biological evaluation and structure-activity relationships of glycyrrhetinic acid derivatives as novel anti-hepatitis B virus agents. Bioorg Med Chem Lett. 2012;22:3473–3479.
  • Rycyn T, Isamy M, Ryuichiro S. Glycyrrhizic acid and its hydrolysate as mineralocorticoid agonist. J Steroid Biochem. 1987;7:845–854.
  • Tolstikov GA, Baltina LA, Serdyuk NG. Glycyrrhetic acid (a review). Pharm Chem J. 1998;32:402–412.
  • Inoue H, Mori T, Shibata S, et al. Pharmacological activities of glycyrrhetinic acid derivatives: analgesic and anti-type IV allergic effects. Chem Pharm Bull. 1987;5:3888–3893.
  • Inoue H, Mori T, Shibata S, et al. Inhibitory effect of glycyrrhetinic acid derivatives on arachidonic acid-induced mouse ear oedema. J Pharm Pharmacol. 1988;40:272–277.
  • Lallemand B, Jabin I, Prevost M, et al. Preparation of 18β-glycyrrhetinic acid derivatives with antitumor activity. WO2012022780A1. 2012.
  • Zhu H, Yan T, Qi H, et al. Glycyrrhetinic acid derivative containing piperazine skeleton, its preparation method and application. CN105669823A. 2016.
  • Cheng K, Huang J, Zhang J, et al. Glycyrrhetinic acid-hydrogen sulfide donor reagent derivative useful in treatment of cancer and its preparation. CN106243182A. 2016.
  • Huai Q, Li Y, Ma Q. Glycyrrhetinic acid, ferulic acid and selenomethionine ternary compound useful in treatment of cancer and its preparation. CN106046105A. 2016.
  • Lin CN, Lin KW, Huang AM, et al. Derivative of 18β-glycyrrhetinic acid apt to suppress cancer cells. US20130109752A1. 2013.
  • Zheng Z, Yu Y, Zhang W, et al. Complex of polyethylene glycol-modified glycyrrhetinic acid and curcumin for treating liver cancer and its preparation method. CN104707148A. 2015.
  • Ding H, Yue Y, Wu S, et al. Glycyrrhetinic acid deriv. Useful in treatment of various diseases and its preparation. CN104530176A. 2015.
  • Qiu W, Yi Z, Liu M, et al. Glycyrrhetinic acid derivative, its preparation method and application in preparation of anti-tumor agents. CN103772477A. 2014.
  • Meng Y, Ding J, Nie H, et al. A modified glycyrrhetinic acid compound with anti-tumor activity and its preparation method. CN102516350A. 2012.
  • Wang T, Li Q. Glycyrrhetinic acid derivatives and the preparation method, pharmaceutical application as antineoplastic medicine. CN102399256A. 2012.
  • Xu C, Ju Y, Gao Z, et al. 3-Acyl-2-ene-glycyrrhetinic acid with antitumor activity and synthetic method. CN102268061A. 2011.
  • Lai Y, Sha L, Miao Z, et al. Glycyrrhetinic acid derivatives with 1,12-diene-3-one skeleton, their preparation method and medicinal application as antitumor agents. CN102250189A. 2011.
  • Lai Y, Wang Z, Shen L, et al. Novel glycyrrhetinic acid derivatives, the preparation and application as anti-tumor agents. CN101775059A. 2010.
  • Wang C, Jin X, Yuan J, et al. Glycyrrhetinic acid acylhydrazone derivative useful in treatment of bacterial infection and its preparation. CN106008653A. 2016.
  • Shi L, Yuan J, Zhong H, et al. Glycyrrhetinic acid isopentane amide derivative useful in treatment of bacterial infection and its preparation. CN106008652A. 2016.
  • Huang L, Yang X, Li Q, et al. A cyclic multi-oxidized substituted glycyrrhetinic acid derivative, preparation method and application. CN103923158A. 2014.
  • Li L, Ma Z, Miao J, et al. Method for preparing glycyrrhetinic acid from Glycyrrhiza uralensis. CN102653550A. 2012.
  • Yang L, Zou L, Ge G, et al. Pentacyclic triterpenoid compound as human intestinal carboxylesterase inhibitor and its preparation. CN105713064A. 2016.
  • Yang L, Zou L, Ge G, et al. Pentacyclic triterpenoid compound as human intestinal carboxylesterase inhibitor and its preparation. WO2016086496A1. 2016.
  • Classen-Houben D, Kueenburg B, Kosma P, et al. Novel triterpene derivatives as 11β- hydroxysteroid dehydrogenase inhibitors. WO2012020019A1. 2012.
  • Classen-Houben D, Kueenburg B, Kosma P, et al. Glycyrrhetinic acid amine analogues for use in the treatment of inflammation, infectious diseases, cancer, autoimmune diseases, skin diseases, bone diseases and metabolic diseases. WO2012020021A1. 2012.
  • Classen-Houben D, Kueenburg B, Kosma P, et al. N-hydroxy C29-amide derivatives of oleandrane for the treatment of diseases mediated by 11β-HSD. WO2010103046A1. 2010.
  • Tao Z, Zhang N, Zhou Y, et al. Matrine derivatives with antitumor activity. CN105254631A. 2016.
  • Zhao C, Zhao L Pentacyclic triterpenoid compounds useful in treatment of cancer and their preparation. CN104530171A. 2015.
  • Visht S. Synthesis of glycyrrhetinic acid-curcumin ester as anticancer agent. IN2014DE01576A. 2014.
  • Zhang H, Zhou J, Han Y, et al. Preparation of glycyrrhetinic acid derivatives for protecting liver. CN102690316A. 2012.
  • Ao G, Xu G, Yang S, et al. Application of glycyrrhetinic acid derivatives for preparing anti-inflammatory medicine. CN102579462A. 2012.
  • Ao G, Qiao C, Hou B, et al. Glycyrrhetinic acid derivative and its application as antitumor agent. CN102241726A. 2011.
  • Rao GSRS, Kondaiah P, Singh SK, et al. Chemical modifications of natural triterpenes- glycyrrhetinic and boswellic acids: evaluation of their biological activity. Tetrahedron. 2008;64:11541–11548.
  • Salomatina OV, Salakhutdinov NF, Tolstikov GA, et al. Me 2-cyano-3,12-dioxo-18βH- olean-1(2),11(9)-dien-30-oate as anti-oxidant, anti-inflammatory, neuroprotective, hypolipidemic, hypocholesterolemic, hypoglycemic, hepatoprotective and immunosuppressive agent. WO2014011085A1. 2014; RU2487884C1. 2013.
  • Wagner R, Chen HJ, Shanley J, et al. Preparation of glycyrrhetinic acid derivatives and methods of use thereof. WO2014040052A2. 2014.
  • Lai Y, Long W, Lai Z, et al. Glycyrrhetinic acid derivatives, preparation method and medical application. CN102702298A. 2012.
  • Takeuchi H, Suzumura A Preparation of glycyrrhetinic acid derivatives as gap junction inhibitors for treating nervous system diseases. WO2015076325A1. 2015.
  • Chang CC, Wang T Use of glycyrrhetinic acid or its pharmaceutically acceptable salt and prodrugs in treatment of hyperprolactinemia. CN103845338A. 2014.
  • Akasaka H, Suzuki H Analgesics containing glycyrrhetinic acid derivative. JP2012250936A. 2012.
  • Xu W, Wang J, Tang L, et al. New application of glycyrrhetinic acid-30-amide-like derivative. CN102813662A. 2012.
  • Du G, Lv Y, Tian S, et al. Glycyrrhetinic acid crystal b form substance and its application in producing the medical formulations and health product for treating addison’s disease and inflammatory enteritis, and preventing and treating pulmonary fibrosis. CN102786573A. 2012.
  • Gao Y, Li S Glycyrrhetinic acid hydrogel preparation, and preparation method and application thereof. CN102784095A. 2012.
  • Zhang L, Zhang W, Xu J, et al. Use of glycyrrhetinic acid, glycyrrhizic acid and related compounds for prevention and/or treatment of pulmonary fibrosis. US20120053141A1. 2012.
  • Gao Y, Wang J, Jia J, et al. 3-O-Caffeoyl-oleate type pentacyclic triterpenoid ester derivative, preparation method and medical application. CN102344481A. 2012.
  • Zhang A, Zhang X, Xia C, et al. 11-Deoxy-18α-glycyrrhetinic acid derivatives, their synthesis and medical application. CN101899081A. 2010.
  • Ren X, Si D, Xu W, et al. Glycyrrhetinic acid-30-amide derivative liquid capsule, and preparation method and medical application thereof. CN101897680A. 2010.
  • Gonos E, Chinou I, Chondrogianni N Anti-aging and whitening properties of quercetin, 18α-glycyrrhetinic acid, hederagenin and its derivatives. EP2246037A2. 2010.
  • Lin CN, Maitraie D, Wang JP, et al. Method for the synthesis of 18β-glycyrrhetinic acid derivatives. US20110039922A1. 2011.
  • Zhang X, Yang J, Xi K, et al. Application of 18β-glycyrrhetinic acid in preparation of medicine for treating allergic rhinitis. CN105596350A. 2016.
  • Wen X, Sun H, Jiang L, et al. Pentacyclic triterpenoid enterovirus 71 inhibitor, and pharmaceutical compositions and medical uses thereof. CN104840467A. 2015.
  • He Y Pharmaceutical composition containing enoxolone and application thereof. CN106074688A. 2016.
  • Liu C, Liu Y, Zheng F A gel and its making method and use in preventing and treating oral ulcers caused by different reasons. CN105342987A. 2016.
  • Ji H, Zhang Y, Dou C, et al. Glycyrrhetinic acid composition and its application. CN104825459A. 2015.
  • Ban K, Ito K Pore penetration enhancer of glycyrrhetinic acid, antimicrobial composition, deodorant composition, and antiperspirant deodorant composition. JP2015134736A. 2015.
  • Hirose N, Nakahara D Licorice hydrolysis extraction composition. WO2014148422A1. 2014.
  • Csuk R. Recent developments in the synthesis of antitumor-active alycyrrhetinic acid derivatives. Mini-Rev Org Chem. 2014;11:253–261.
  • Bednarczyk-Cwynar B, Zaprutko L. Recent advances in synthesis and biological activity of triterpenic acylated oximes. Phytochem Rev. 2015;14:203–231.
  • Inoue H, Saito H, Koshihara Y, et al. Inhibitory effect of glycyrrhetinic acid derivatives on lipoxygenase and prostaglandin synthetase. Chem Pharm Bull. 1986;34:897–901.
  • Cao Y, Tang XY, Song FW. Compare of and beta-glycyrrhetinic acid alpha- glycyrrhetinic acid in the treatment of chronic hepatitis B. China J Modern Med. 2002;12:91–92.
  • Lin D, Sun W, Wang Z, et al. The effect of glycyrrhetinic acid on Pharmacokinetics of cortisone and its metabolite cortisol in rats. J Biomed Biotechnol. 2012;1–5. Article ID 856324.
  • Li XL, Zhou AG, Zhang L, et al. Antioxidant status and immune activity of glycyrrhizin in allergic rhinitis mice. Int J Mol Sci. 2011;12:905–916.
  • Azimov MM, Zakirov UB, Radzhapova SD. Pharmacological study of the anti- inflammatory reagent glyderinine. Farmakol Toksikol. 1988;4:90–93.
  • Irismetov MP, Nikonov GK. Abstract/Paper. The 4rth All-Union Symposium on the Study and commercial use of Licorice [in Russian]. Gylym, Alma-Ata 1991; p. 168. .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.